Minapharm buys CMO ProBioGen for €30.4m
Egypt-based Minapharm has acquired 95 per cent of CMO ProBioGen for a possible total of €30.4m ($37.6m).
News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs
News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs
Egypt-based Minapharm has acquired 95 per cent of CMO ProBioGen for a possible total of €30.4m ($37.6m).